| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 66,090 | 55,981 | 54,333 | 60,753 | | Cost of Revenue | 54,703 | 51,811 | 48,340 | 52,768 | | | Gross Profit | 11,387 | 4,170 | 5,993 | 7,985 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,657 | 12,722 | 13,082 | 12,650 | | Non Recurring |
-
|
-
|
-
| 17,409 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (270) | (8,552) | (7,089) | (22,074) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7) | 29 | 127 | (130) | | Earnings Before Interest And Taxes | (277) | (8,523) | (6,962) | (22,204) | | Interest Expense | 278 | 198 | 134 | 99 | | Income Before Tax | (555) | (8,721) | (7,096) | (22,303) | | Income Tax Expense | (282) | (2,783) | (2,576) | (8,509) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (273) | (5,938) | (4,520) | (13,794) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (273) | (5,938) | (4,520) | (13,794) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($273) | ($5,938) | ($4,520) | ($13,794) |
|
0.59% Nasdaq 
0.06 (1.06%) 
Income Statement
